Sunday, 20 September 2026European Markets

GRAINES VOLTZ And IMCD Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(vianews) - graines voltz (grvo.pa) is among this list of stock assets with the highest dividend rate and return on equity on the basic materials sector.

financial asset price forward dividend yield return on equity
graines voltz (grvo.pa) €27.05 3.98% 0.46%
imcd (imcd.as) €142.45 1.66% 17.66%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. graines voltz (grvo.pa)

3.98% forward dividend yield and 0.46% return on equity

graines voltz s.a. distributes vegetable and flower seeds in france and europe. it also offers vegetables, herbs, and edible flowers. it serves professionals, horticulturists, nurserymen, landscapers, and private and public communities. the company was incorporated in 1985 and is headquartered in colmar, france.

earnings per share

as for profitability, graines voltz has a trailing twelve months eps of €0.45.

pe ratio

graines voltz has a trailing twelve months price to earnings ratio of 60.11. meaning, the purchaser of the share is investing €60.11 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.46%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on mar 29, 2022, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 3.98%.

revenue growth

year-on-year quarterly revenue growth grew by 0.9%, now sitting on 132.96m for the twelve trailing months.

volume

today's last reported volume for graines voltz is 309 which is 82.04% below its average volume of 1721.

more news about graines voltz.

2. imcd (imcd.as)

1.66% forward dividend yield and 17.66% return on equity

imcd n.v. distributes, markets, and sells specialty chemicals and ingredients in the netherlands, rest of europe, the middle east, africa, north america, south america, and the asia-pacific. the company offers bioactives, biocides, chelates, functional additives, rheology modifiers, silicones, solubilisers, and solvents; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, uv sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. it also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, binders, corrosion inhibitors, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. imcd n.v. was founded in 1995 and is headquartered in rotterdam, the netherlands.

earnings per share

as for profitability, imcd has a trailing twelve months eps of €5.05.

pe ratio

imcd has a trailing twelve months price to earnings ratio of 28.21. meaning, the purchaser of the share is investing €28.21 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.66%.

moving average

imcd's value is under its 50-day moving average of €146.76 and higher than its 200-day moving average of €133.70.

sales growth

imcd's sales growth is 0.3% for the present quarter and 1% for the next.

more news about imcd.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com